EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis

Hye-Bin Seung, Hui-Ju Kwon, Chan-Young Kwon iD, Sang-Ho Kim iD

Pharmaceuticals · 18.08.2023 · 16 (8) · 1176

DOI: 10.3390/ph16081176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 18.08.2023. Verfasst von Hye-Bin Seung und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a medical condition involving persistent sadness and loss of interest; however, conventional treatments with antidepressants and cognitive behavioral therapy have limitations. Based on the pathogenesis of MDD, treatments using herbal medicines (HM) have been identified in animal studies. We conducted a systematic review of clinical studies to identify neurobiological outcomes and evaluate the effectiveness of HM in treating MDD. A meta-analysis was performed by searching nine databases from their inception until 12 September 2022, including 31 randomized controlled trials with 3133 participants, to examine the effects of HM on MDD using neurobiological biomarkers and a depression questionnaire scale. Quality assessment was performed using a risk of bias tool. Compared to antidepressants alone, HM combined with an antidepressant significantly increased concentrations of serotonin (SMD = 1.96, 95% CI: 1.24–2.68, p < 0.00001, I2 = 97%), brain-derived neurotrophic factor (SMD = 1.38, 95% CI: 0.92–1.83, p < 0.00001, I2 = 91%), and nerve growth factors (SMD = 2.38, 95% CI: 0.67–4.10, p = 0.006, I2 = 96%), and decreased cortisol concentrations (SMD = −3.78, 95% CI: −4.71 to −2.86, p < 0.00001, I2 = 87%). Although HM or HM with an antidepressant benefits MDD treatment through improving neuroendocrine factors, these findings should be interpreted with caution because of the low methodological quality and clinical heterogeneity of the included studies.

Schlagwörter

Stichwörter der Autor:innen

complementary integrative medicineherbal medicinemajor depressive disordermeta-analysisneurobiological factor

Autor:innen und Institutionen

  • College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.
  • Department of Oriental Neuropsychiatry, Dong-Eui University College of Korean Medicine, Busan 47227, Republic of Korea.
  • Department of Neuropsychiatry of Korean Medicine, Pohang Korean Medicine Hospital, Daegu Haany University, 411 Saecheonnyeon-daero, Nam-gu, Pohang-si 790-826, Republic of Korea.

ORCID-Profile: Chan-Young Kwon, Sang-Ho Kim

Förderung

  • the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
  • Korea Health Technology R&amp;D Project through the Korea Health Industry Development Institute (KHIDI)

Zitieren

APA

Seung, H. B., Kwon, H. J., Kwon, C. Y., & Kim, S. H. (2023). Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis. Pharmaceuticals, 16(8), 1176. https://doi.org/10.3390/ph16081176

Vancouver

Seung HB, Kwon HJ, Kwon CY, Kim SH. Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2023;16(8):1176. doi:10.3390/ph16081176

BibTeX
@article{Seung2023,
  author = {Seung, Hye-Bin and Kwon, Hui-Ju and Kwon, Chan-Young and Kim, Sang-Ho},
  title = {Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {8},
  pages = {1176},
  doi = {10.3390/ph16081176}
}
Kostenlos starten →